Radiochemistry,Production Processes,Labeling Methods,and ImmunoPET Imaging Pharmaceuticals of Iodine-124

Target-specific biomolecules, monoclonal antibodies (mAb), proteins, and protein fragments are known to have high specificity and affinity for receptors associated with tumors and other pathological conditions. However, the large biomolecules have relatively intermediate to long circulation half-lives (>day) and tumor localization times. Combining superior target specificity of mAbs and high sensitivity and resolution of the PET (Positron Emission Tomography) imaging technique has created a paradigm-shifting imaging modality, ImmunoPET. In addition to metallic PET radionuclides, ¹²⁴I is an attractive radionuclide for radiolabeling of mAbs as potential immunoPET imaging pharmaceuticals due to its physical properties (decay characteristics and half-life), easy and routine production by cyclotrons, and well-established methodologies for radioiodination. The objective of this report is to provide a comprehensive review of the physical properties of iodine and iodine radionuclides, production processes of ¹²⁴I, various ¹²⁴I-labeling methodologies for large biomolecules, mAbs, and the development of ¹²⁴I-labeled immunoPET imaging pharmaceuticals for various cancer targets in preclinical and clinical environments. A summary of several production processes, including ¹²³Te(d,n)¹²⁴I, ¹²⁴Te(d,2n)¹²⁴I, ¹²¹Sb(α,n)¹²⁴I, ¹²³Sb(α,3n)¹²⁴I, ¹²³Sb(³He,2n)¹²⁴I, ^natSb(α, xn)¹²⁴I, ^natSb(³He,n)¹²⁴I reactions, a detailed overview of the ¹²⁴Te(p,n)¹²⁴I reaction (including target selection, preparation, processing, and recovery of ¹²⁴I), and a fully automated process that can be scaled up for GMP (Good Manufacturing Practices) production of large quantities of ¹²⁴I is provided. Direct, using inorganic and organic oxidizing agents and enzyme catalysis, and indirect, using prosthetic groups, ¹²⁴I-labeling techniques have been discussed. Significant research has been conducted, in more than the last two decades, in the development of ¹²⁴I-labeled immunoPET imaging pharmaceuticals for target-specific cancer detection. Details of preclinical and clinical evaluations of the potential ¹²⁴I-labeled immunoPET imaging pharmaceuticals are described here.     

Obtaining of a PET-CaF2 hybrid multifilament: Non-isothermal crystallization studies

Poly(ethylene terephthalate) (PET) has been mixed with fluorite (CaF₂) particles to obtain micro- and nano-composites aiming to obtain a hybrid multifilament. In first term, the use of two montanic waxes and an amide wax as dispersing agents towards the compatibilization of the inorganic and organic components of the CaF₂/PET composite were considered. To do this, non-isothermal crystallization studies by differential scanning calorimetry have been carried out. Moreover, the influence of the CaF₂ particle size and concentration on the thermal properties of the system have been also studied by this technique. Finally, the extrapolation of the results has materialised as a novel PET/CaF₂ hybrid multifilament. Thermal and mechanical properties and molecular weight of the multifilament have been as well evaluated.     

颗粒材料三维应力路径下的接触组构特性

颗粒材料的宏观应力变形特征与其微观接触力、组构等紧密相关.一般而言,强接触系统属于颗粒内部体系的传力结构,其对应的组构张量是影响宏观应力性质的重要因素.细观数值方法(如离散单元法)能够反映物理试验的基本规律,并且可以方便地提取宏微观数据来研究颗粒体系的应力变形机制.采用离散单元法(discrete element method,DEM)进行一系列等$p$等$b$应力路径下颗粒材料的真三轴试验,在此基础上研究了三维应力路径下颗粒材料的宏微观力学参数的演化过程、三维组构张量与应力张量多重联系以及强接触体系反映的宏观应力特征.研究表明:颗粒体系偏应力峰值状态和临界状态均存在与加载路径无关的宏微观特征;三维应力路径下组构张量与应力张量存在非共轴性,但其联合不变量演化过程表现出加载路径无关的特征;与弱接触系统的组构张量相比,强接触系统的组构张量更能反映宏观应力张量的特征;强弱接触体系的组构张量对颗粒体系宏观响应的贡献不同,其分界点存在一定取值范围,但采用平均接触力较为简单合理.      

Glass fabrics self-cracking catalytic growth of boron nitride nanotubes

Glass fabrics were used to fabricate boron nitride nanotubes (BNNTs) with a broad diameter range through a combined chemical vapor deposition and self-propagation high-temperature synthesis (CVD-SHS) method at different holding times (0min, 30min, 90min, 180min and 360min). SEM characterization has been employed to investigate the macro and micro structure/morphology changes of the glass fabrics and BNNTs in detail. SEM image analysis has provided direct experimental evidences for the rationality of the optimized self-cracking catalyst VLS growth mechanism, including the transformation situations of the glass fabrics and the BNNTs growth processes respectively. This paper was the further research and compensation for the theory and experiment deficiencies in the new preparation method of BNNTs reported in our previous work. In addition, it is likely that the distinctive self-cracking catalyst VLS growth mechanism could provide a new idea to preparation of other inorganic functional nano-materials using similar one-dimensional raw materials as growth templates and catalysts.     

Citronellol-Based Long-Lasting Antibacterial Cotton Fabrics without Bacterial Resistance

Antibacterial cotton helps prevent the growth and spread of harmful microorganisms, reduces the risk of infection, and has a prolonged service life by reducing bacterial degradation. However, most antibacterial agents used are toxic to humans and the environment. Citronellol-poly(N,N-dimethyl ethyl methacrylate) (CD), a highly effective antibacterial polymer, is synthesized from natural herbal essential oils (EOs). CD exhibited efficient, rapid bactericidal activity against Gram-positive, Gram-negative, and drug-resistant bacteria. Citronellol's environmental benignity makes CDs less hemolytic. Notably, negligible drug resistance developed after 15 bacterial subcultures. The CD-treated cotton fabric displayed better antibacterial performance than AAA-grade antibacterial fabric, even after repeated washing. This study extends the practical application of EOs to antibacterial surfaces and fabrics, which is promising for use in personal care products and medical settings.     

Recycling of polyethylene terephthalate (PET Or PETE) plastics – An alternative to obtain value added products: A review

Waste management is become one of the world's most pressing issues. Plastic is one of the most widely utilised materials in the modern world. Plastic manufacturing and usage have risen globally in recent decades due to its low weight and outstanding mechanical properties. Plastic has a wide range of applications due to such good properties include lightweight, high strength, and extended durability. Because of plastics are non- or low-biodegradable, a vast quantity of plastic waste is generated every day, making waste disposal the most pressing matter globally. Furthermore, improper waste disposal pollutes the environment. An ecologically friendly approach is necessary to locket these issues. One of the solutions is to recycle this sort of garbage. There are many plastic recycling technologies available, however practically all of them have certain restrictions. Chemical recycling of plastic, on the other hand, has been shown to be more efficient than other recycling methods. This article provides a quick overview of chemical recycling of PET post-consumer waste and the synthesis of potentially value-added products such as dye or dyestuffs, bolaform surfactant, bio-degradable polyesters, drug carrier, Metal-organic framework (MOF), bio-degradable polymeric scaffolds, polyurethane foam and coating materials etc.     

PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin αvβ3 Receptors

Multimeric ligands consisting of multiple pharmacophores connected to a single backbone have been widely investigated for diagnostic and therapeutic applications. In this review, we summarize recent developments regarding multimeric radioligands targeting integrin α_vβ₃ receptors on cancer cells for molecular imaging and diagnostic applications using positron emission tomography (PET). Integrin α_vβ₃ receptors are glycoproteins expressed on the cell surface, which have a significant role in tumor angiogenesis. They act as receptors for several extracellular matrix proteins exposing the tripeptide sequence arginine-glycine-aspartic (RGD). Cyclic RDG peptidic ligands c(RGD) have been developed for integrin α_vβ₃ tumor-targeting positron emission tomography (PET) diagnosis. Several c(RGD) pharmacophores, connected with the linker and conjugated to a chelator or precursor for radiolabeling with different PET radionuclides (¹⁸F, ⁶⁴Cu, and ⁶⁸Ga), have resulted in multimeric ligands superior to c(RGD) monomers. The binding avidity, pharmacodynamic, and PET imaging properties of these multimeric c(RGD) radioligands, in relation to their structural characteristics are analyzed and discussed. Furthermore, specific examples from preclinical studies and clinical investigations are included.     

光子晶体结构色织物研究进展

针对结构色织物难以产业化的现状,从光学效应和能够产生结构色的周期性结构两个角度系统介绍了结构色织物生色机理。随后,按照结构色织物表面光子晶体结构特征、所用光子晶体基元种类及结构色制备方法,对结构色织物进行了系统分类归纳,并指出了各自的优缺点。此外,现有结构色织物研究均为基于已有纳米粒子尺寸来表征对应结构色颜色,缺乏根据实际颜色需求选取光子晶体尺寸的研究。我们根据现有文献报道的光子晶体基元尺寸与所得结构色织物颜色种类的对应关系,通过计算得到了根据所需织物颜色种类确定光子晶体基元尺寸的公式。最后总结了结构色织物制备存在的问题,并给出了合理建议。     

Clinical Perspectives of Theranostics

Theranostics is a precision medicine which integrates diagnostic nuclear medicine and radionuclide therapy for various cancers throughout body using suitable tracers and treatment that target specific biological pathways or receptors. This review covers traditional theranostics for thyroid cancer and pheochromocytoma with radioiodine compounds. In addition, recent theranostics of radioimmunotherapy for non-Hodgkin lymphoma, and treatment of bone metastasis using bone seeking radiopharmaceuticals are described. Furthermore, new radiopharmaceuticals for prostatic cancer and pancreatic cancer have been added. Of particular, F-18 Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography (PET) is often used for treatment monitoring and estimating patient outcome. A recent clinical study highlighted the ability of alpha-radiotherapy with high linear energy transfer (LET) to overcome treatment resistance to beta--particle therapy. Theranostics will become an ever-increasing part of clinical nuclear medicine.     

Design,Synthesis, and Validation of a Novel [11C]Promethazine PET Probe for Imaging Abeta Using Autoradiography

Promethazine, an antihistamine drug used in the clinical treatment of nausea, has been demonstrated the ability to bind Abeta in a transgenic mouse model of Alzheimer’s disease. However, so far, all of the studies were performed in vitro using extracted tissues. In this work, we report the design and synthesis of a novel [¹¹C]promethazine PET radioligand for future in vivo studies. The [¹¹C]promethazine was isolated by RP-HPLC with radiochemical purity >95% and molar activity of 48 TBq/mmol. The specificity of the probe was demonstrated using human hippocampal tissues via autoradiography.